| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000025870 |
| Receipt No. | R000029736 |
| Scientific Title | Clinical study for early diagnosis of cancer metastasis by exosomes in serum |
| Date of disclosure of the study information | 2017/01/28 |
| Last modified on | 2022/01/31 (Ver. 3) |
| Basic information | ||
| Public title | Clinical study for early diagnosis of cancer metastasis by exosomes in serum | |
| Acronym | Early diagnosis of cancer metastasis by exosomes | |
| Scientific Title | Clinical study for early diagnosis of cancer metastasis by exosomes in serum | |
| Scientific Title:Acronym | Early diagnosis of cancer metastasis by exosomes | |
| Region |
|
|
| Condition | ||
| Condition | sarcoma | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate metastatic risk of cancer patient by analysis of exosomes in serum |
| Basic objectives2 | Others |
| Basic objectives -Others | Analyze exosomes of cancer patient before starting treatment |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Diagnostic accuracy of metastasis |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Diagnosed with malignancy
ECOG Performance Status 0to 3 5 years old or more WBC over 2,000/mm3 Plt over 50,000/mm3 Hb over 8.0g/dl |
|||
| Key exclusion criteria | severe heart disease, renal dyfunction, respiratory failure, caogulation disorder
double cancer pregnant Other medical, social, or psychological conditions that in the opinion of an investigator precludes the patient from appropriate consent |
|||
| Target sample size | 70 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kanazawa Univ | ||||||
| Division name | Orthopaedic department | ||||||
| Zip code | 920-8641 | ||||||
| Address | Takaramachi 13-1, Kanazawa, Japan | ||||||
| TEL | 0762652374 | ||||||
| khayashi830@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kanazawa Univ | ||||||
| Division name | Orthopaedic department | ||||||
| Zip code | 920-8641 | ||||||
| Address | Takaramachi 13-1, Kanazawa, Japan | ||||||
| TEL | 0762652374 | ||||||
| Homepage URL | |||||||
| khayashi830@gmail.com | |||||||
| Sponsor | |
| Institute | Kanazawa Univ |
| Institute | |
| Department | |
| Funding Source | |
| Organization | self |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | IRB Kanazawa Univ |
| Address | Takaramachi13-1, Kanazawa |
| Tel | 0762652000 |
| rinri@adm.kanazawa-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Patients who are treated in Kanazawa Univ |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029736 |